Enveric Biosciences, Inc.

( )
AMRH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
ARGXargenx SE 0.97%367.890.0%$115.64m
ICLRICON plc 0.00%220.632.8%$108.26m
VRXValeant Pharmaceuticals International, Inc. 4.00%9.1114.1%$53.60m
RVMDRevolution Medicines, Inc. 0.00%18.870.0%$18.72m
AMRNAmarin Corp. Plc 0.52%1.931.5%$8.79m
EVOKEvoke Pharma, Inc. 0.00%3.0439.7%$8.00m
USNAUSANA Health Sciences, Inc. 0.03%74.284.2%$5.51m
BGXXBright Green Corp. -0.70%2.820.0%$5.38m
ANIKAnika Therapeutics, Inc. 0.00%22.539.8%$3.30m
ATOSAtossa Therapeutics, Inc. 1.71%1.190.2%$2.74m
CDXCChromadex Corp. 0.00%1.922.7%$1.63m
SMFLSmart for Life, Inc. -7.75%0.520.0%$1.57m
IBIOiBio, Inc. 2.34%0.320.2%$1.39m
FLGCFlora Growth Corp. 0.00%0.730.0%$0.93m
NATRNature's Sunshine Products, Inc. 0.00%11.130.4%$0.89m

Company Profile

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.